Brown et al. 1999, ATCC 700504
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us  to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Gram-positive, nonmotile and acid-fast rods.
- Smooth to mucoid, off-white to cream coloured colonies. Yellow to orange pigment produced in 78% of all strains, after 10-14 days incubation.
- Rapid growth on Middlebrook 7H10 and trypticase soy agar at 30°C, 35°C and 45°C within 2-4 days.
- Susceptible to amikacin, ethambutol, sulfamethoxazole.
- Intermediate susceptible to ciprofloxacin, doxycycline and tobramycin.
- Variable susceptible to cefmetazole, cefoxitin and clarithromycin.
- Resistant to isoniazid and rifampicin.
- Comparable clinical settings to M. smegmatis and members of the M. fortuitum complex.
- Production of post-traumatic wound infections especially those following open fractures and with associated osteomyelitis and chronic lipoid pneumonia.
First isolated from a patient with a post-traumatic osteomyelitis of the heel(USA). Strain MO69 = ATCC 700504 = CIP 106349 = DSM 44492 = JCM 12689. Mycobacterium goodii was previously known as Mycobacterium smegmatis group 2.
- Brown et al. 1999. Mycobacterium wolinskyi sp. nov. and Mycobacterium goodii sp. nov., two new rapidly growing species related to Mycobacterium smegmatis and associated with human wound infections: a cooperative study from the International Working Group on Mycobacterial Taxonomy. Int. J. Syst. Bacteriol., 1999, 49, 1493-1511.
de:Mycobacterium goodii nl:Mycobacterium goodii